Brain Cancer | Specialty

The OncLive Brain Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of brain cancer, including glioma, glioblastoma multiforme, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in brain cancer.

Bevacizumab Results Offer Support for Upfront Therapy

February 5th 2013

Several recent clinical trials have yielded positive data that may open up new treatment options for patients with glioblastoma.

Meningioma May Be Tied to Dental X-Rays

November 29th 2012

New data suggest that dental x-rays obtained frequently at a young age may boost the risk of intracranial meningioma.

Chemoradiation Established as New Standard in Glioma Subtypes

August 14th 2012

A study that unfolded over 17 years has established combination chemotherapy after radiotherapy as a new standard of care for patients with anaplastic oligodendroglial tumors that contain 1p/19q chromosomal co-deletions.

Unexpected Mutations Doom Therapy for Glioblastoma

June 25th 2012

Unexpected target mutations likely doomed a proven therapeutic approach to lung cancer in a test against glioblastoma.

Surviving Brain Cancer During Pregnancy

April 9th 2012

Antonia Reyes was 39 years old and 18 weeks pregnant when an MRI revealed an apparent glioma in the right temporal-parietal lobe region.

Clinical Management of Primary Brain Tumors

January 6th 2012

At NCONN 2011, Sean Grimm, MD, discussed the management of Glioblastoma multiforme, the most common malignant primary brain tumor.

Dr. Grimm on the Brain Cancer Predictive Marker MGMT

November 4th 2011

Dr. Sean Grimm from Northwestern University, Feinberg School of Medicine on MGMT as a Predictive Marker in Brain Cancer

Valproic Acid May Prolong Survival in Glioblastoma

November 1st 2011

New data suggest that patients with glioblastoma who are treated with valproic acid, an antiepileptic drug (AED), are likely to outlive patients who receive another type of AED or no AED at all.

Dr. Grimm Discusses Primary Brain Cancer Risk Factors

October 31st 2011

Dr. Grimm from Northwestern University, Feinberg School of Medicine Discusses Brain Cancer Risk Factors

ASCO Highlights: Trials in Progress

August 23rd 2011

The following is a roundup of TPS abstracts that feature trials open to patients aged >17 years with a broad range of cancer types.

Trastuzumab and Chemotherapy Prolong Survival in Patients With Breast Cancer and CNS Metastases

July 18th 2011

Treatment with Herceptin, chemotherapy, or surgery extended the lives of patients with HER2-positive MBC following a diagnosis of CNS metastases.

5 Abstracts Offer Snapshot of Immunology Research

July 15th 2011

The field of immunotherapy is brimming with questions that researchers are working to answer, and many of those efforts were on display at the ASCO annual meeting.

Afinitor Halves SEGA Tumor Size in Patients With Tuberous Sclerosis

July 11th 2011

In the phase III EXIST-1 trial, Afinitor reduced the size of SEGAs-benign brain tumors associated with TSC-by â‰¥50% in one-third of patients.

Rethinking Initial Management of Patients With Brain Metastasis and HER2 Breast Cancer

June 6th 2011

Lapatinib and capecitabine is a reasonable approach in a well-informed patient with brain metastasis and HER2+ breast cancer

Oncology Links From Across the Web for Brain Cancer

May 19th 2011

Links to resource from across the web for brain cancer; includes news briefs, patient education, research and clinical trials

Dendritic Cell Vaccine Promising

May 18th 2011

A dendritic cell vaccine under development may increase median survival time in patients with glioblastoma

FDA Approves Novel Device to Treat Brain Cancer

April 18th 2011

The FDA has approved a novel device that uses electric fields to treat aggressive brain tumors

FDA Panel Backs Experimental Brain Cancer Treatment

March 30th 2011

An FDA panel voted 7 to 3 (2 abstentions) in support of the NovoTTF-100A System

Miles for Hope: Cancer Survivor Works to Raise Awareness and Funding for Brain Tumor Research

March 15th 2011

Bob Gibbs knows the importance of cancer research and the life-saving therapies it creates. The 40-year-old husband and father of 4 would not be alive today without these new discoveries and innovations.

Crisis Averted? Manufacturers Scurry to Meet Demand for Drugs

March 12th 2011

The shortage, which began in 2009, accelerated in 2010, and has shown no signs of abatement so far in 2011, according to Erin R. Fox, PharmD, manager of the Drug Information Service at University of Utah Health Care